AGING AND VULNERABILITY TO 6HYDROXYDOPAMINE
衰老和对 6 羟基多巴胺的脆弱性
基本信息
- 批准号:2751212
- 负责人:
- 金额:$ 7.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2000-09-29
- 项目状态:已结题
- 来源:
- 关键词:6 hydroxydopamine aging brain metabolism corpus striatum developmental neurobiology disease /disorder model dopamine drug administration rate /duration high performance liquid chromatography laboratory rat model design /development neurotoxicology nucleus accumbens potassium channel prefrontal lobe /cortex substantia nigra
项目摘要
This application is from a new investigator and is aimed at research
topic 16 - sensory and motor processing. The nigrostriatal dopamine (DA)
system of the brain has been shown to play a major role in the control
of movement. A gradual loss of nigrostriatal dopamine neurons occurs
during normal aging in humans, and many elderly persons display one or
more of the signs of Parkinson's disease without having the disease.
This may indicate that older people that have parkinsonian signs may
have a greater than normal loss of nigrostriatal DA. Although the cause
for the normally occurring loss of midbrain DA cells in the elderly is
not known, animal studies have indicated that the DA neurons of older
animals may be more vulnerable to the effects of various neurotoxins.
The purpose of the experiments in the present application is too
determine if the nigrostriatal DA system of older animals is more
sensitive to the neurotoxic effects of the dopaminergic toxin 6-
hydroxydopamine (6-OHDA), and to begin to develop a model of the aging
brain that is partially depleted of DA. It is hypothesized that the
nigrostriatal DA system in older rats will be more sensitive to the
neurotoxic effects of 6-OHDA than the nigrostriatal DA system of younger
rats. The initial set of experiments will be to generate a dose-
response curve in young adult animals for the DA-depleting effects of
6-OHDA. Male Fischer-344 rats (4 months old) will be given a single,
unilateral injection of 6-OHDA into the right lateral ventricle. The
doses examined will be 0, 50, 100, 150, and 200 mug of 6-OHDA per
injection. Three weeks later, DA and metabolite levels will be measured
in the striatum, nucleus accumbens, substantia nigra, and medial
prefrontal cortex. Based on the results of these experiments, a dose
of 6-OHDA that reduces striatal DA levels by approximately 50 percent
in young adult rats will given to rats of three ages; 4 months, 18
months, and 24 months old. Three weeks later the rats will be
anesthetized and in vivo electrochemistry experiments will be carried
out on both sides of the brain to map out potassium-evoked overflow of
DA, and subsequent clearance of DA, in the striatum. Following the
experiments, post-mortem levels of DA and metabolites will be measured
to determine the extent of whole tissue depletion by the 6-OHDA. The
results of these experiments will help determine if the nigrostriatal
DA system of the aging rat brain is more susceptible to the neurotoxic
effects of 6-OHDA, and will begin to determine possible differences in
presynaptic dopaminergic functioning in the aging versus younger brain
in response to a neurotoxic insult.
这个应用程序是从一个新的调查员,旨在研究
主题16 -感觉和运动处理。黑质纹状体多巴胺(DA)
大脑的一个系统已经被证明在控制中起着重要的作用。
的运动。 黑质纹状体多巴胺神经元逐渐丧失,
在人类的正常衰老过程中,许多老年人表现出一种或
更多的帕金森病的迹象,而没有这种疾病。
这可能表明有帕金森症状的老年人可能
黑质纹状体DA的损失比正常情况下更大。虽然原因
老年人中脑DA细胞的正常丢失,
动物研究表明,老年人的DA神经元
动物可能更容易受到各种神经毒素的影响。
本申请中的实验的目的也是
确定老年动物的黑质纹状体DA系统是否更
对多巴胺能毒素6-
羟基多巴胺(6-OHDA),并开始开发衰老模型,
大脑中的DA部分耗尽。据推测,
老年大鼠的黑质纹状体DA系统将对
6-OHDA的神经毒性作用比年轻的黑质纹状体DA系统
大鼠 最初的实验将产生一个剂量-
年轻成年动物中DA消耗效应的反应曲线
6-OHDA。 雄性Fischer-344大鼠(4月龄)将给予单次,
将6-OHDA单侧注射到右侧脑室。 的
检查的剂量为0、50、100、150和200 μ g 6-OHDA/
注射 三周后,将测量DA和代谢物水平
在纹状体、中脑核、黑质和内侧核中,
前额皮质 根据这些实验的结果,
6-OHDA可使纹状体DA水平降低约50%
在年轻的成年大鼠将给予三个年龄的大鼠; 4个月,18
一个月,一个24个月。 三个星期后,老鼠将
将进行麻醉和在体电化学实验
在大脑两侧绘制出钾诱发的溢出,
DA,以及随后的DA清除。 后
在实验中,将测量DA和代谢物的死后水平
以确定6-OHDA对整个组织的消耗程度。 的
这些实验的结果将有助于确定黑质纹状体是否
衰老大鼠脑内DA系统对神经毒素更敏感
6-OHDA的影响,并将开始确定可能的差异,
老年人与年轻人大脑中的突触前多巴胺能功能
以应对神经毒性损伤。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAYNE A CASS其他文献
WAYNE A CASS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAYNE A CASS', 18)}}的其他基金
RECOVERY FROM METHAMPHETAMINE INDUCED NEURODEGENERATION
从甲基苯丙胺引起的神经变性中恢复
- 批准号:
2608210 - 财政年份:1997
- 资助金额:
$ 7.29万 - 项目类别:
RECOVERY FROM METHAMPHETAMINE INDUCED NEURODEGENERATION
从甲基苯丙胺引起的神经变性中恢复
- 批准号:
2013459 - 财政年份:1997
- 资助金额:
$ 7.29万 - 项目类别:
RECOVERY FROM METHAMPHETAMINE INDUCED NEURODEGENERATION
从甲基苯丙胺引起的神经变性中恢复
- 批准号:
2837871 - 财政年份:1997
- 资助金额:
$ 7.29万 - 项目类别:
RECOVERY FROM METHAMPHETAMINE INDUCED NEURODEGENERATION
从甲基苯丙胺引起的神经变性中恢复
- 批准号:
6125032 - 财政年份:1997
- 资助金额:
$ 7.29万 - 项目类别:
RECOVERY FROM METHAMPHETAMINE INDUCED NEURODEGENERATION
从甲基苯丙胺引起的神经变性中恢复
- 批准号:
6329145 - 财政年份:1997
- 资助金额:
$ 7.29万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




